title: Population pharmacokinetics of mycophenolic acid in kidney transplant pediatric and adolescent patients.
abstract: Current data on mycophenolate mofetil (MMF) suggest that there is a pharmacokinetic/pharmacodynamic relationship between the mycophenolic acid (MPA) area under the curve (AUC) during treatment and both the risk of acute rejection and the occurrence of side effects. The aim of this study was to characterize the population pharmacokinetics of MPA in kidney transplant patients between the ages of 2 and 21 years and to propose a limited sampling strategy to estimate individual MPA AUCs. Forty-one patients received long-term oral MMF continuous therapy as part of a triple immunosuppressive regimen, which also included cyclosporine or tacrolimus (n=3) and corticosteroids. Therapy was initiated at a dose of 600 mg/m twice daily. The population parameters were calculated from an initial group of 32 patients. The data were analyzed by nonlinear mixed-effect modeling using a 2-compartment structural model with first-order absorption and a lag time. The interindividual variability in the initial volume of distribution was partially explained by the fact that this parameter was weight-dependent. Fifteen concentration-time profiles from 13 patients were used to evaluate the predictive performance of the Bayesian approach and to devise a limited sampling strategy. The protocol, involving two sampling times, 1 and 4 hours after oral administration, allows the precise and accurate determination of MPA AUCs (bias -0.9 microg.h/mL; precision 6.02 microg.h/mL). The results of this study combine the relationships between the pharmacokinetic parameters of MPA and patient covariates, which may be useful for dose adjustment, with a convenient sampling procedure that may aid in optimizing pediatric patient care.
authors.affiliation: Clinical Pharmacokinetics Laboratory, Faculty of Pharmacy, University Montpellier I, Montpellier, France.
authors.forename: S
authors.initials: S
authors.lastname: Payen
authors.forename: D
authors.initials: D
authors.lastname: Zhang
authors.forename: A
authors.initials: A
authors.lastname: Maisin
authors.forename: M
authors.initials: M
authors.lastname: Popon
authors.forename: A
authors.initials: A
authors.lastname: Bensman
authors.forename: F
authors.initials: F
authors.lastname: Bouissou
authors.forename: C
authors.initials: C
authors.lastname: Loirat
authors.forename: R
authors.initials: R
authors.lastname: Gomeni
authors.forename: F
authors.initials: F
authors.lastname: Bressolle
authors.forename: E
authors.initials: E
authors.lastname: Jacqz-Aigrain
mesh_terms: D000293:Adolescent; D019540:Area Under Curve; D001499:Bayes Theorem; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics*; D016030:Kidney Transplantation; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000493:pharmacokinetics*
chemical_list: D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid